QB3 "4x4" Bio VC Pitch Session Fall 2026

​What makes an emerging biotech company investable? And more specifically, what most appeals to strategic investors, backing startups whose technologies align with the scope of large pharma?

​In QB3's "4x4" pitch session series, startup founders participating in QB3's early-stage programs pitch active investors for live feedback in a public setting.

​Join us to learn and network with current and future entrepreneurs in UC Berkeley's vibrant ecosystem. Students (grad and undergrad) and postdocs, founders and the entrepreneurially-minded are very welcome.

​VC judges: Shawna Frazier (AbbVie Ventures), Lior Teitelbaum (JJDC), and Tim Luker (Lilly Ventures).

​Companies pitching: Adjuva Bio: RNA platform to treat fibrotic disease; Inixi Bio: Blocking initiation of hereditary cancers; Lucina Biotherapeutics: First-in-class lipid therapies for aging-related disease; NeoVariant Bio: In stealth mode!